SCP logo

Scope Fluidics S.A. Stock Price

WSE:SCP Community·zł384.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 5 Fair Values set on narratives written by author

SCP Share Price Performance

zł0
-152.60 (-100.00%)
zł0
-152.60 (-100.00%)
Price zł0

SCP Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with reasonable growth potential.

2 Risks
2 Rewards

Scope Fluidics S.A. Key Details

zł104.0k

Revenue

zł4.1m

Cost of Revenue

-zł4.0m

Gross Profit

zł44.8m

Other Expenses

-zł48.8m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Sep 30, 2026
-15.41
-3,873.08%
-46,959.62%
0%
View Full Analysis

About SCP

Founded
2010
Employees
157
CEO
Piotr Garstecki
WebsiteView website
www.scopefluidics.com

Scope Fluidics S.A., a biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland. It offers BacterOMIC, an antibiotic susceptibility testing. Scope Fluidics S.A. was founded in 2010 and is headquartered in Warsaw, Poland.

Recent SCP News & Updates

Recent updates

No updates